Mentari Therapeutics, Inc. (MTRI)
12.22
-3.78
(-23.62%)
USD |
NASDAQ |
Nov 10, 16:00
12.80
+0.58
(+4.75%)
After-Hours: 16:29
Mentari Therapeutics Total Assets (Quarterly) : 1.306M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.306M |
| June 30, 2026 | 3.030M |
| March 31, 2026 | 9.134M |
| December 31, 2025 | 11.19M |
| September 30, 2025 | 13.36M |
| June 30, 2025 | 15.58M |
| March 31, 2025 | 9.280M |
| December 31, 2024 | 8.502M |
| September 30, 2024 | 10.47M |
| June 30, 2024 | 11.82M |
| March 31, 2024 | 13.36M |
| December 31, 2023 | 15.26M |
| September 30, 2023 | 10.92M |
| June 30, 2023 | 14.11M |
| March 31, 2023 | 14.73M |
| December 31, 2022 | 16.92M |
| September 30, 2022 | 14.58M |
| June 30, 2022 | 12.79M |
| March 31, 2022 | 15.49M |
| December 31, 2021 | 19.38M |
| September 30, 2021 | 17.33M |
| June 30, 2021 | 9.781M |
| March 31, 2021 | 12.34M |
| December 31, 2020 | 9.221M |
| September 30, 2020 | 6.308M |
| Date | Value |
|---|---|
| June 30, 2020 | 7.803M |
| March 31, 2020 | 8.399M |
| December 31, 2019 | 10.89M |
| September 30, 2019 | 12.74M |
| June 30, 2019 | 15.14M |
| March 31, 2019 | 16.73M |
| December 31, 2018 | 18.04M |
| September 30, 2018 | 20.35M |
| June 30, 2018 | 21.33M |
| March 31, 2018 | 11.89M |
| December 31, 2017 | 11.72M |
| September 30, 2017 | 6.065M |
| June 30, 2017 | 6.419M |
| March 31, 2017 | 3.335M |
| December 31, 2016 | 1.670M |
| September 30, 2016 | 1.266M |
| June 30, 2016 | 1.212M |
| March 31, 2016 | 1.154M |
| December 31, 2015 | 1.095M |
| September 30, 2015 | 1.117M |
| June 30, 2015 | 1.330M |
| March 31, 2015 | 1.218M |
| December 31, 2014 | 1.349M |
| September 30, 2014 | 1.501M |
| June 30, 2014 | 1.592M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NervGen Pharma Corp. | 63.57M |
| Milestone Pharmaceuticals, Inc. | 181.62M |
| Appili Therapeutics, Inc. | 0.9129M |
| Clearmind Medicine, Inc. | 16.91M |
| Lexaria Bioscience Corp. | 4.781M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.505M |
| Shareholders Equity (Quarterly) | -1.199M |
| Current Ratio | 0.5043 |
| Net Debt Paydown Yield | 0.20% |